drugset / Trial / NCT06655519
An Exploratory Study of RD140 Injection in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia
NaSingle-groupOpen-labelTreatment
Summary
This is a single-center, open clinical study, divided into two phases of dose escalation and dose expansion, to observe the safety and efficacy of RD140 injection at different doses in patients with relapsed/refractory multiple myeloma or plasmacytic leukemia.
Timeline
- Start
- 2024-10-25
- Primary completion
- 2028-07-05
- Completion
- 2041-07-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RD140 | Cell therapy | 100000 cells/kg | — |
| Subject | RD140 | Cell therapy | 300000 cells/kg | — |
| Subject | RD140 | Cell therapy | 600000 cells/kg | — |